JOHN N KAPOOR
CIK 1033150 · President & CEO · last filed 2018-01-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$21.47M
Companies
5
Total Filings
45
Lifetime Open-Market Net
-$50.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKORN INC (AKRX) Delisted | Director | 2,413,432 | — | — | -$52.53M | 24 | 2018-01-26 |
| Insys Therapeutics, Inc. (INSY) Delisted | President & CEO | 42,479,792 | — | — | $1.57M | 9 | 2017-08-14 |
| NEOPHARM INC (NEOL) Delisted | Chairman of the Board | 5,210,151 | — | — | $84.1K | 7 | 2008-08-26 |
| INGN | Director | 3,354,995 | $6.40 | $21.47M | $0 | 3 | 2008-06-13 |
| OPTION CARE INC/DE (OPTN) Delisted | Director | 3,305,173 | $9.60 | $31.73M | $0 | 1 | 2007-06-07 |
Recent Filings · Page 4 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-08-26 | NEOPHARM INC (NEOL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-06-13 | INGN | Grant (A) | — | $0 | EDGAR |
| 2008-06-09 | NEOPHARM INC (NEOL) Delisted | Buy (P) | +11,500 | $9.6K | EDGAR |
| 2008-06-05 | NEOPHARM INC (NEOL) Delisted | Buy (P) | +45,000 | $31.7K | EDGAR |
| 2008-06-03 | NEOPHARM INC (NEOL) Delisted | Buy (P) | +38,100 | $24.9K | EDGAR |
| 2008-05-30 | NEOPHARM INC (NEOL) Delisted | Buy (P) | +30,400 | $17.8K | EDGAR |
| 2008-03-24 | AKORN INC (AKRX) Delisted | Buy (P) | +40,000 | $186.9K | EDGAR |
| 2008-03-20 | AKORN INC (AKRX) Delisted | Buy (P) | +5,000 | $23.3K | EDGAR |
| 2008-03-18 | AKORN INC (AKRX) Delisted | Buy (P) | +5,000 | $22.6K | EDGAR |
| 2007-12-20 | NEOPHARM INC (NEOL) Delisted | Grant (A) | +60,913 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.